array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(453)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(90) "The SEFH and GSK join forces to promote the training quality of hospital pharmacy in Spain"
["snippet_en"]=>
string(151) "Both entities have signed an institutional collaboration framework that provides continuity to a series of training projects, the most notable of which"
["url"]=>
string(125) "https://www.immedicohospitalario.es/noticia/43499/la-sefh-y-gsk-se-unen-para-fomentar-la-calidad-formativa-de-la-farmaci.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b35e4468-256a-42d0-a0e3-76a2f355e7ca"
["source"]=>
string(23) "immedicohospitalario.es"
["publication_date"]=>
string(10) "2024-01-10"
["categories"]=>
array(2) {
[0]=>
string(13) "Collaboration"
[1]=>
string(20) "Business Development"
}
}
[1]=>
array(7) {
["title_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["snippet_en"]=>
string(87) "GSK considering expanding its respiratory business with Verona Pharma and its COPD drug"
["url"]=>
string(59) "https://www.merca2.es/2024/01/03/gsk-verona-pharma-1530796/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b38e2896-a81f-4186-a8b2-31e7a0f364aa"
["source"]=>
string(9) "merca2.es"
["publication_date"]=>
string(10) "2024-01-02"
["categories"]=>
array(3) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[2]=>
array(7) {
["title_en"]=>
string(48) "GSK recognized as a Business Example #PorElClima"
["snippet_en"]=>
string(113) "The pharmaceutical company is part of the 10 large companies and 10 SMEs that are a model to follow in this field"
["url"]=>
string(128) "https://www.consalud.es/salud35/sostenibilidad/reconocen-gsk-ejemplo-empresarial-clima-compromiso-medio-ambiente_137104_102.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e51e62ec-f3a1-4394-a5f6-1427b68dcdb4"
["source"]=>
string(11) "consalud.es"
["publication_date"]=>
string(10) "2023-11-21"
["categories"]=>
array(3) {
[0]=>
string(22) "Business Restructuring"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(20) "Business Development"
}
}
[3]=>
array(7) {
["title_en"]=>
string(69) "Pfizer to exit GSK consumer health joint venture after London listing"
["snippet_en"]=>
string(68) "US pharma group to sell down stake in Haleon business after July IPO"
["url"]=>
string(63) "https://www.ft.com/content/85f28cd9-ca18-4f2b-8346-c22efdfe1382"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e34c335d-d226-4780-91d7-3c2c05e08aa6"
["source"]=>
string(6) "ft.com"
["publication_date"]=>
string(10) "2022-06-01"
["categories"]=>
array(9) {
[0]=>
string(8) "Downtime"
[1]=>
string(12) "Going Public"
[2]=>
string(11) "Acquisition"
[3]=>
string(18) "General Investment"
[4]=>
string(13) "Collaboration"
[5]=>
string(25) "Business Model Resilience"
[6]=>
string(20) "Business Development"
[7]=>
string(10) "Divestment"
[8]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(48) "Bilfinger receives maintenance contract from GSK"
["snippet_en"]=>
string(266) "The industrial service provider Bilfinger has received a project and maintenance contract for the production facilities in Montrose, Scotland, from the pharmaceutical company Glaxosmithkline (GSK). The three-year contract is worth the equivalent of 15 million euros."
["url"]=>
string(104) "https://www.pharma-food.de/utilities-services/bilfinger-erhaelt-instandhaltungs-auftrag-von-gsk-104.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/356ba01f-4726-4512-93bd-c3e37b7b29d1"
["source"]=>
string(14) "pharma-food.de"
["publication_date"]=>
string(10) "2021-09-13"
["categories"]=>
array(5) {
[0]=>
string(20) "Contract negotiation"
[1]=>
string(15) "Deals & Tenders"
[2]=>
string(23) "Supply Chain Management"
[3]=>
string(17) "Production Issues"
[4]=>
string(20) "Business Development"
}
}
[5]=>
array(7) {
["title_en"]=>
string(65) "Groundbreaking ceremony in Marburg: GSK invests 162 million euros"
["snippet_en"]=>
string(220) "Construction work on the new Glaxo Smith Kline (GSK) meningococcal B facility began on March 20th. With an investment volume of 162 million euros, the group is continuing to implement its future plans on the Mars campus."
["url"]=>
string(88) "https://www.pharma-food.de/markt/spatenstich-in-marburg-gsk-investiert-162-mio-euro.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a527549b-0440-4360-bb96-935c0ac8c32a"
["source"]=>
string(14) "pharma-food.de"
["publication_date"]=>
string(10) "2017-03-22"
["categories"]=>
array(5) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(19) "Investment Requests"
[2]=>
string(18) "General Investment"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(20) "Business Development"
}
}
[6]=>
array(7) {
["title_en"]=>
string(65) "ANALYSIS FLASH: Jefferies upgrades GSK to 'Buy' and targets 1900p"
["snippet_en"]=>
string(213) "Sprylab GmbH is an innovative technology company based in Berlin, Germany. The company specializes in the development of digital solutions and content management systems for publishers, media houses and companies."
["url"]=>
string(104) "https://www.boersen-zeitung.de/ticker/analyse-flash-jefferies-hebt-gsk-auf-buy-und-ziel-auf-1900-pence-4"
["image_url"]=>
NULL
["source"]=>
string(18) "boersen-zeitung.de"
["publication_date"]=>
NULL
["categories"]=>
array(5) {
[0]=>
string(5) "R & D"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(13) "Data Security"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(20) "Business Development"
}
}
[7]=>
array(7) {
["title_en"]=>
string(52) "Barclays leaves GSK at 'Equal Weight' - target 1575p"
["snippet_en"]=>
string(213) "Sprylab GmbH is an innovative technology company based in Berlin, Germany. The company specializes in the development of digital solutions and content management systems for publishers, media houses and companies."
["url"]=>
string(94) "https://www.boersen-zeitung.de/ticker/barclays-belaesst-gsk-auf-equal-weight-ziel-1575-pence-2"
["image_url"]=>
NULL
["source"]=>
string(18) "boersen-zeitung.de"
["publication_date"]=>
NULL
["categories"]=>
array(3) {
[0]=>
string(5) "R & D"
[1]=>
string(13) "Data Security"
[2]=>
string(20) "Business Development"
}
}
[8]=>
array(7) {
["title_en"]=>
string(81) "GSK as a Business Example #PorElClima thanks to its commitment to the environment"
["snippet_en"]=>
string(138) "The pharmaceutical company is part of the 10 large companies and 10 SMEs that are a role model in decarbonization, measuring the impact..."
["url"]=>
string(138) "https://www.acobur.es/noticia/enlaces-externos/gsk-como-ejemplo-empresarial-porelclima-gracias-a-su-compromiso-con-el-medio-ambiente-31892"
["image_url"]=>
NULL
["source"]=>
string(9) "acobur.es"
["publication_date"]=>
NULL
["categories"]=>
array(2) {
[0]=>
string(19) "Green & Responsible"
[1]=>
string(20) "Business Development"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(29)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(27)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[19]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(5)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
453 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
Both entities have signed an institutional collaboration framework that provides continuity to a series of training projects, the most notable of which
The industrial service provider Bilfinger has received a project and maintenance contract for the production facilities in Montrose, Scotland, from the pharmaceutical company Glaxosmithkline (GSK). The three-year contract is worth the equivalent of 15 million euros.
Construction work on the new Glaxo Smith Kline (GSK) meningococcal B facility began on March 20th. With an investment volume of 162 million euros, the group is continuing to implement its future plans on the Mars campus.
Sprylab GmbH is an innovative technology company based in Berlin, Germany. The company specializes in the development of digital solutions and content management systems for publishers, media houses and companies.
Sprylab GmbH is an innovative technology company based in Berlin, Germany. The company specializes in the development of digital solutions and content management systems for publishers, media houses and companies.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
